U.S., April 2 -- ClinicalTrials.gov registry received information related to the study (NCT06903728) titled 'National Trial of CGM in Pregnant Women With Type 2 Diabetes' on March 25.
Brief Summary: The goal of this clinical trial is to evaluate the use of glucose sensors in pregnant women with type 2 diabetes to improve insulin regulation, pregnancy and birth outcomes, and enhance quality of life and satisfaction with treatment.
The main questions it aims to answer are:
* Does the use of glucose sensors during pregnancy lead to a clinically significant reduction in HbA1c by 0.3% at 36 weeks gestation compared to the control group?
* Does the use of glucose sensors during pregnancy result in a clinically significant reduction in mean SD...